Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001601830-25-000075
Filing Date
2025-05-05
Accepted
2025-05-05 06:02:27
Documents
83
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rxrx-20250331.htm   iXBRL 10-Q 910233
2 EX-31.1 exhibit311-q0125.htm EX-31.1 7592
3 EX-31.2 exhibit312-q0125.htm EX-31.2 7564
4 EX-32.1 exhibit321-q0125.htm EX-32.1 3985
10 GRAPHIC rxrx-20250331_g1.jpg GRAPHIC 505935
11 GRAPHIC rxrx-20250331_g2.jpg GRAPHIC 774878
  Complete submission text file 0001601830-25-000075.txt   9446806

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20250331.xsd EX-101.SCH 54458
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rxrx-20250331_cal.xml EX-101.CAL 81297
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rxrx-20250331_def.xml EX-101.DEF 272149
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20250331_lab.xml EX-101.LAB 681744
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20250331_pre.xml EX-101.PRE 470416
86 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20250331_htm.xml XML 721816
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40323 | Film No.: 25910757
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)